Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Koopmans

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Microbiology|March 20, 2015
Has CXCL13 an added value in diagnosis of neurosyphilis?Khutso M Mothapo, Marcel M Verbeek, Lieven B van der Velden, et al.
AIDS (London, England)|November 13, 2015
Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infectionSebastiaan J Hullegie, Brenda C M de Winter, Dirk Posthouwer, et al.
Brain Imaging and Behavior|October 17, 2016
Resting-state subcortical functional connectivity in HIV-infected patients on long-term cARTMarloes A M Janssen, Max Hinne, Ronald J Janssen, et al.
AIDS (London, England)|June 6, 2008
Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medicationsCarolien J P Beukel van den Bout-van den, Marjolein E W Bosch, David M Burger, et al.
Antiviral Therapy|December 3, 2003
A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study)David M Burger, Rob E Aarnoutse, Jeanne P Dieleman, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjectsManon J van der Lee, Audrey A M Blenke, Gerard A Rongen, et al.
Drug Metabolism Reviews|August 1, 2006
Possible drug-metabolism interactions of medicinal herbs with antiretroviral agentsCarolien J P van den Bout-van den Beukel, Peter P Koopmans, André J A M van der Ven, et al.
AIDS (London, England)|June 17, 2005
Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modificationsCharles J L la Porte, Emile F Schippers, Marchina E van der Ende, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
AIDS (London, England)|May 6, 2008
High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tabletsHanneke M J Nijland, Rafaëlla F A L'homme, Gerard A Rongen, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Microbiology|March 20, 2015
Has CXCL13 an added value in diagnosis of neurosyphilis?Khutso M Mothapo, Marcel M Verbeek, Lieven B van der Velden, et al.
AIDS (London, England)|November 13, 2015
Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infectionSebastiaan J Hullegie, Brenda C M de Winter, Dirk Posthouwer, et al.
Brain Imaging and Behavior|October 17, 2016
Resting-state subcortical functional connectivity in HIV-infected patients on long-term cARTMarloes A M Janssen, Max Hinne, Ronald J Janssen, et al.
AIDS (London, England)|June 6, 2008
Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medicationsCarolien J P Beukel van den Bout-van den, Marjolein E W Bosch, David M Burger, et al.
Antiviral Therapy|December 3, 2003
A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study)David M Burger, Rob E Aarnoutse, Jeanne P Dieleman, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjectsManon J van der Lee, Audrey A M Blenke, Gerard A Rongen, et al.
Drug Metabolism Reviews|August 1, 2006
Possible drug-metabolism interactions of medicinal herbs with antiretroviral agentsCarolien J P van den Bout-van den Beukel, Peter P Koopmans, André J A M van der Ven, et al.
AIDS (London, England)|June 17, 2005
Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modificationsCharles J L la Porte, Emile F Schippers, Marchina E van der Ende, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
AIDS (London, England)|May 6, 2008
High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tabletsHanneke M J Nijland, Rafaëlla F A L'homme, Gerard A Rongen, et al.
Pageof 5